Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
BMC Pulm Med
; 21(1): 253, 2021 Jul 31.
Article
in En
| MEDLINE
| ID: mdl-34332555
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Peloideterapia
Main subject:
Pulmonary Disease, Chronic Obstructive
/
Medication Adherence
Type of study:
Etiology_studies
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
America do norte
Language:
En
Journal:
BMC Pulm Med
Year:
2021
Type:
Article
Affiliation country:
United States